| Doris Ann May, CNS | |
|
6655 E Us Highway 36, Avon, IN 46123-8923 | |
| (317) 272-3330 | |
| (317) 272-0807 |
| Full Name | Doris Ann May |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - School |
| Location | 6655 E Us Highway 36, Avon, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306997275 | NPI | - | NPPES |
| 100270530A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SS0200X | Clinical Nurse Specialist - School | 70000042A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Doris Ann May, CNS 6655 E Us Highway 36, Avon, IN 46123-8923 Ph: (317) 272-3330 | Doris Ann May, CNS 6655 E Us Highway 36, Avon, IN 46123-8923 Ph: (317) 272-3330 |
News Archive
Dana-Farber Cancer Institute's Belfer Institute of Applied Cancer Science (Belfer Institute) and sanofi-aventis announced today that they have entered into a collaboration and license option agreement to identify and validate novel oncology targets for further discovery and development by sanofi-aventis of novel therapeutics agents directed to such targets and related biomarkers.
Big data and mobile technology are playing key roles in the recovery from strokerelated language and cognitive impairment, according to an internal study conducted by Constant Therapy, which provides a sciencebased, customized brain rehabilitation software program.
With the help of forest residues such as sawdust, branches and tops and cellulose from sea squirts, researchers in Biochemical Process Engineering at Luleå University of Technology, want to make our stomach to feel better.
Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
› Verified 5 days ago
Kathy Santon, APRN, BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 192 N State Road 267, Suite 300, Avon, IN 46123 Phone: 317-268-6555 Fax: 317-268-6556 | |
Samantha Kate Biddle, RN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 812-249-6242 | |
Jennifer L Woodard, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1115 N Ronald Reagan Pkwy, Ste 141, Avon, IN 46123 Phone: 317-962-2929 Fax: 317-962-2070 | |
Ann Allison, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-3367 | |
Erica Newkirk, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-3205 |